• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Closing the Stable Door After the Horse Has Bolted: Should We Be Treating People With Immune-Tolerant Chronic Hepatitis B to Prevent Hepatocellular Carcinoma?

作者信息

Howell Jessica, Chan Henry L Y, Feld Jordan J, Hellard Margaret E, Thompson Alexander J

机构信息

Department of Gastroenterology, St Vincent's Hospital, Melbourne Australia; Department of Disease Elimination, Burnet Institute, Melbourne Australia; Department of Medicine, University of Melbourne, Melbourne Australia.

Department of Medicine and Therapeutics and Centre for Liver Health, The Chinese University of Hong Kong, Hong Kong China.

出版信息

Gastroenterology. 2020 Jun;158(8):2028-2032. doi: 10.1053/j.gastro.2020.02.027. Epub 2020 Feb 20.

DOI:10.1053/j.gastro.2020.02.027
PMID:32088205
Abstract
摘要

相似文献

1
Closing the Stable Door After the Horse Has Bolted: Should We Be Treating People With Immune-Tolerant Chronic Hepatitis B to Prevent Hepatocellular Carcinoma?亡羊补牢：我们是否应该治疗免疫耐受期慢性乙型肝炎患者以预防肝细胞癌？
Gastroenterology. 2020 Jun;158(8):2028-2032. doi: 10.1053/j.gastro.2020.02.027. Epub 2020 Feb 20.
2
Preventing infection-associated cancer: from bench to hillside.预防感染相关癌症：从实验室到临床实践
J Natl Cancer Inst. 2005 Feb 16;97(4):245-6. doi: 10.1093/jnci/dji059.
3
Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis.抗病毒治疗对慢性病毒性肝炎患者肝细胞癌风险的影响。
Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1277-1282. doi: 10.1097/MEG.0000000000001254.
4
[Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
Eksp Klin Gastroenterol. 2007(2):107-12.
5
Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.致编辑的信：慢性乙型肝炎基线病毒载量与治疗期间肝癌风险：一项针对HBeAg阳性患者的多国队列研究。
Hepatology. 2024 Sep 1;80(3):E46-E47. doi: 10.1097/HEP.0000000000000942. Epub 2024 May 28.
6
Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk-A multinational cohort study of HBeAg-positive patients.致编辑的信：慢性乙型肝炎基线病毒载量与治疗期间肝癌风险——一项HBeAg阳性患者的多国队列研究
Hepatology. 2024 Aug 1;80(2):E26-E27. doi: 10.1097/HEP.0000000000000882. Epub 2024 Apr 12.
7
Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.致编辑的信：慢性乙型肝炎基线病毒载量与治疗期间肝癌风险：一项针对HBeAg阳性患者的多国队列研究。
Hepatology. 2024 Oct 1;80(4):E57. doi: 10.1097/HEP.0000000000000928. Epub 2024 May 14.
8
Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine.慢性乙型肝炎中肝细胞癌的风险评分：精准医学的前景
Hepatology. 2020 Dec;72(6):2197-2205. doi: 10.1002/hep.31440. Epub 2020 Nov 13.
9
Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.全球视角下的慢性乙型肝炎自然史：乙型肝炎病毒基因型 A 至 J 的作用。
Semin Liver Dis. 2013 May;33(2):97-102. doi: 10.1055/s-0033-1345716. Epub 2013 Jun 8.
10
Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up.有效抑制病毒对于降低慢性乙型肝炎肝硬化患者肝细胞癌的发生是必要的：一项10年随访结果
Medicine (Baltimore). 2017 Nov;96(44):e8454. doi: 10.1097/MD.0000000000008454.

引用本文的文献

1
A new approach to prevent, diagnose, and treat hepatitis B in Africa.一种在非洲预防、诊断和治疗乙型肝炎的新方法。
BMC Glob Public Health. 2023;1(1):24. doi: 10.1186/s44263-023-00026-1. Epub 2023 Nov 2.
2
HBV "Viral Elimination" in the Asia-Pacific region: Current status and challenges.亚太地区的乙肝病毒“病毒清除”：现状与挑战
Clin Liver Dis (Hoboken). 2024 Mar 7;23(1):e0132. doi: 10.1097/CLD.0000000000000132. eCollection 2024 Jan-Jun.
3
Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
乙肝病毒相关肝细胞癌持续风险的相关因素综述
Cancers (Basel). 2024 Feb 14;16(4):777. doi: 10.3390/cancers16040777.
4
Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients.降低丙氨酸氨基转移酶阈值以增强对慢性乙型肝炎患者显著肝损伤的识别
World J Gastroenterol. 2023 Sep 21;29(35):5166-5177. doi: 10.3748/wjg.v29.i35.5166.
5
Pathway to global elimination of hepatitis B: HBV cure is just the first step.迈向全球消除乙型肝炎之路：HBV 治愈仅仅是第一步。
Hepatology. 2023 Sep 1;78(3):976-990. doi: 10.1097/HEP.0000000000000430. Epub 2023 May 1.
6
Prevention of malignant digestive system tumors should focus on the control of chronic inflammation.消化系统恶性肿瘤的预防应着重于慢性炎症的控制。
World J Gastrointest Oncol. 2023 Mar 15;15(3):389-404. doi: 10.4251/wjgo.v15.i3.389.
7
A global investment framework for the elimination of hepatitis B.全球消除乙型肝炎投资框架。
J Hepatol. 2021 Mar;74(3):535-549. doi: 10.1016/j.jhep.2020.09.013. Epub 2020 Sep 22.